Suven Pharmaceuticals Ltd.

BSE: 532540 NSE: Suven Pharmaceuticals ISIN:  INE467B01029 SECTOR: IT Software Company Company’s Website: IPO Date & Price: July 29, 2004 | Rs.

Suven Pharmaceuticals Overview:

Stock Symbol in NSEStock Symbol in BSECurrent PriceMarket Cap. (Cr)P/E RatioCurrent EPS
NSE:SUVENPHARBSE: 543064₹489.05₹12,296.81₹34.37₹14.23
52 Week High52 Week LowDay OpenDay HighDay LowVolumes
₹559.35₹159.10₹490.00₹493.80₹476.00₹271,752.00
Current Price Fall From 52W high How Near from 52Week Low?Today ChangesSuven Pharmaceuticals Ltd.Outstanding Shares [Cr.]Face valueLast Traded Time
12.57%67.47%4.65#N/A₹1.006/14/2021 15:30:02
About

Suven Pharmaceuticals

Its the Indian No-1 multinational information service and consulting Provider company. Suven Pharmaceuticals is the Subsidiary Company of TATA Group and it’s founded in 1968.

Suven Pharmaceuticals Sector Performance and Peer Comparison with Sector Analysis:

Did You Know?

<Space for Feature Image>

  • Suven Pharmaceuticals is the
  • Its Belong to Group.

Balance Sheets & Profit & Loss Account:

YearMar 2019Mar 2020
Net Profit109317
EPS in Rs.5,463.5012.45
Dividend Payout %0%20%
Dividend2.49
Profit Grouth Rates190.83%
Avearge Profit Grouth Rates

Suven Pharmaceuticals Share Price Forecast Based on Current Growth +5/-5:

Share Price and EPS Forecast Based on Current Average Growth Rates:

Next 5 Years (CG)Next 20 Years (CG)Next 10 Years (CG)
₹317.00₹317.00₹317.00
₹12.45₹12.45₹12.45
₹249.00₹249.00₹249.00
₹311.25₹311.25₹311.25
₹373.50₹373.50₹373.50
₹435.75₹435.75₹435.75

Share Price and EPS Forecast Based on Current Average Growth Rates Plus 5%:

Next 5 Years (CG+5%)Next 10 Years (CG+5%)Next 20 Years (CG+5%)
₹404.58₹516.36₹841.10
₹15.89₹20.28₹12.45
₹317.79₹405.59₹249.00
₹397.24₹506.99₹311.25
₹476.69₹608.39₹373.50
₹556.14₹709.79₹435.75

Share Price and EPS Forecast Based on Current Average Growth Rates Minus 5%:

Next 20 Years (CG-5%)Next 10 Years (CG-5%)Next 5 Years (CG-5%)
₹113.64₹189.80₹245.29
₹4.46₹7.45₹9.63
₹89.26₹149.09₹192.67
₹111.58₹186.36₹240.84
₹133.89₹223.63₹289.01
₹156.21₹260.90₹337.18

Suven Pharmaceuticals Quarterly Result, Date & Street Estimate:

Share NameQuarter ResultsYearStreet EstimatesProfitsGrowth
Suven Pharmaceuticals LtdQ1 Results2021
Suven Pharmaceuticals LtdQ2 Results2021
Suven Pharmaceuticals LtdQ3 Results2021
Suven Pharmaceuticals LtdQ4 Results2021
Suven Pharmaceuticals LtdQ1 Results2020
Suven Pharmaceuticals LtdQ2 Results2020
Suven Pharmaceuticals LtdQ3 Results2020
Suven Pharmaceuticals LtdQ4 Results2020

Fundamental Analysis of Suven Pharmaceuticals :

Suven Pharmaceuticals Share Long Term Investment Price Target:

PriceLong Term Investment TagetsQnt.Ratio
₹391.55Lot-120 [1X]
₹363.58Lot-240 [2X]
₹335.61Lot-380 [4X]
₹307.64Lot-4180 [8X]

Suven Pharmaceuticals Fundamentals SWAT Analysis by AMT

 Strengths, Weaknesses, Opportunities, and Threats of Suven Pharmaceuticals

S

  • Strengths Analysis will coming Soon.

W

  • Weakness Analysis will coming Soon.

O

  • Opportunity Analysis will coming Soon.

T

  • Threats Analysis will coming Soon.

Where we can See Suven Pharmaceuticals in Next 5 Year, 10 Year & 20 Year?

Technical Analysis of Suven Pharmaceuticals :

Suven Pharmaceuticals Share Weekly Swing Trading Price Target:

Demand And Supply ZoneSupport LevelsSupport PriceResistance LevelsResistance Price
250S-1250R-1N/A
226S-2226R-2N/A
217S-3217R-3N/A
202S-4202R-4N/A
191S-5191R-5N/A
183S-6183R-6N/A
166S-7166R-7N/A
158S-8158R-8N/A
141S-9141R-9N/A
S-100R-10N/A
S-110R-11N/A
S-120R-12N/A
S-130R-13N/A
S-140R-14N/A
S-150R-15N/A

Suven Pharmaceuticals Share Today Intraday Price Target:

IntradayTarget Today [Short Selling]IntradayTarget Today [Long Buying]
₹519.40₹460.60
₹525.77₹457.66
N/AN/A
N/AN/A

FAQ on Suven Pharmaceuticals :

Is it Good to Buy Suven Pharmaceuticals Share?

Yes, Suven Pharmaceuticals is India Number-1 IT Software company, with lots business potential in next few year. Its Fundamentally strong Stock we recommend to buy at around 20-25 PE Ration price target. Anyway This company is quite famous for Good Dividends.

Is Suven Pharmaceuticals Debt Free Company?

Suven Pharmaceuticals is a Debt free company. Its can easily survived any down turn for 5-10 Quarter business growth.

Is Suven Pharmaceuticals Overvalued?

Currently Suven Pharmaceuticals is Trading at P/E Ratio which is

Is Suven Pharmaceuticals Better than Infosys?

Both and working as a

Why Suven Pharmaceuticals Share Price is Falling?

Do to Covid-19 pandemic Suven Pharmaceuticals Share drastically fall.

Why Suven Pharmaceuticals Share Price is Going Up?

Is Suven Pharmaceuticals Good for Long Term Investment?

Its depend on when you and at what price you have buy this share, Suven Pharmaceuticals at 20-25 P/E Ration is a excellent buy call for long Term Investment.

Suven Pharmaceuticals ‘s Products/Projects:

Products/ProjectsDescription/Valuation
A.
B.
C.

IPO, Split, Bonus, Dividend Buyback History:

Suven Pharmaceuticals First IPO was initiate on July 29, 2004. equity shares were put on sale during the IPO with a price band of Rs -Rs per equity share.

[ninja_tables id=”82019″

Company Profile:

CEO NameVenkateswarlu Jasti
CFO NameM Mohan Kumar
CEO SalaryN/A
Company Address3rd Floor, # 8-2-334, SDE Serene Chambers, Rd Number 5, Avenue – 7, Banjara Hills, Hyderabad, Telangana 500034
Contact Number040 2354 9414
Email Addresscontactsuvenusa@suven.com …

Declaration: Investing in the Stock market is full of Risky. AllMoneyTips.COM doesn’t give any guarantee or warranted on its investment advice. Do your research before investing in the stock market. Our Forecast and buying selling levels of stocks is based on price action and demand and supply zone. There is no guarantee come with our prediction. Take it as advice only. We are not responsible for your losses on your investments.